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ABSTRACT
Oxidative stress is currently viewed as a key factor in the genesis and progression 
of Heart Failure (HF). The aim of this study was to characterize the mitochondrial 
changes linked to oxidative stress generation in circulating peripheral blood 
mononuclear cells isolated from chronic HF patients (HF_PBMCs) in order to highlight 
the involvement of mitochondrial dysfunction in the pathophysiology of HF.
To assess the production of reactive oxygen species (ROS), mitochondrial 
function and ultrastructure and the mitophagic flux in circulating PBMCs we enrolled 
15 patients with HF and a control group of ten healthy subjects. The HF_PBMCs 
showed a mitochondrial population consisting of damaged and less functional 
organelles responsible of higher superoxide anion production both at baseline and 
under in vitro stress conditions, with evidence of cellular apoptosis. Although the 
mitophagic flux at baseline was enhanced in HF_PBMCs at level similar to those that 
could be achieved in control PBMCs only under inflammatory stress conditions, the 
activation of mitophagy was unable to preserve a proper mitochondrial dynamics 
upon stress stimuli in HF.
In summary, circulating HF_PBMCs show structural and functional derangements 
of mitochondria with overproduction of reactive oxidant species. This mitochondrial 
failure sustains a leucocyte dysfunctional status in the blood that may contribute to 
development and persistence of stress conditions within the cardiovascular system in HF.
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INTRODUCTION
Heart failure (HF) is a clinical syndrome affecting 
more than 23 millions of patients worldwide with a high 
associated morbidity and mortality [1]. Over the last 30 
years several improvements in treatments favored survival 
in these patients but the prognosis remains unsatisfactory. 
In order to better understand HF and to identify the 
best therapeutic options, it is important to fully investigate 
the underlying pathophysiological mechanisms. 
Oxidative stress and chronic inflammation are key 
factors involved in the pathophysiology of HF [2]. In this 
context, the role of mitochondrial dysfunction appears to 
be of increasing importance [3]. 
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Mitochondria are the main source of intracellular 
ATP. They also control cell death and survival by 
integrating information from multiple signaling pathways 
[4]. The mitochondrial network exhibits high tissue 
specificity in relation with the cell functions. Any change 
of the internal organization of mitochondria could impair 
cell energetics and, as a consequence, cell function and 
viability [5]. 
The cardiac mitochondria produce 90% of the 
required ATP. They occupy one third of the cell volume, 
are embedded in a dense and complex organization and are 
able to adjust their morphology and location depending on 
the energy need and the metabolic status [6]. 
To ensure the maintenance of the morpho-functional 
integrity of the mitochondrial network and to mantain the 
normal cell function and tissue homeostasis, a quality 
control of the mitochondrial structure is essential [7]. 
In fact, mitochondria are constantly under dynamic 
events to adapt themselves toward changes in the 
cellular environment. Specifically, the full equilibrium 
between mitochondrial fusion and fission, together 
with the elimination of dysfunctional mitochondria and 
mitochondrial biogenesis, represents a crucial mechanism 
to ensure mitochondrial homeostasis [8, 9]. 
Fusion of reversibly damaged mitochondria with 
healthy ones can favor their functional repair. Fission 
allows the maintenance of functional mitochondria by 
segregating damaged parts. However, when mitochondria 
incur irreversible damage, fission leads to selective 
elimination of the damaged organelles by mitochondrial-
specific autophagy, referred to as mitophagy [10]. 
Oxidative damage contributes to impairment of the 
electron transport chain, to mitochondrial uncoupling, 
and, ultimately, to bioenergetic dysfunction characterized 
by reduced ATP production and further accumulation 
of ROS [11]. Finally, oxidative stress is associated with 
mitochondrial transition pore opening, which promotes 
cell death [12]. At ultrastructural level, the findings of 
mitochondrial suffering were related to a progressive 
reduction of mitochondrial surface associated with intact 
cristae and relevant reduction of internal mitochondrial 
membrane (IMM) length with respect to outer 
mitochondrial membrane (OMM), namely IMM/OMM 
index [13, 14].
In the presence of cellular damage caused by 
excessive ROS production from aberrant mitochondria, 
the cells activate mitophagy [12, 15, 16]. This process 
involves the activation of PTEN induced kinase 1 (PINK1) 
and of parkin [12]. 
Mitochondrial dysfunction has been previously 
reported in dilated cardiomyopathy [17] and in failing hearts 
[18]. Experimental studies in animals with pressure overload-
induced left- and right- ventricular failure show increased 
mitochondrial ROS generation [19, 20]. The myocardial 
oxidative stress deteriorates cardiac function by inducing 
cellular damage and death [21]. Interestingly, the role of 
mitochondrial dysfunction present in circulating peripheral 
blood mononuclear cells (PBMCs) has been previously 
involved in the pathophysiology of HF [22–24]. Moreover, 
the role of reactive oxygen species generated by PBMCs 
has been explored in patients with cardiovascular disease 
[25] and HF [24]. Surprisingly, the available data show that 
PBMCs undergo changes similar to failing cardiomyocytes 
in HF [26]. In fact, studies on leukocyte mitochondria in 
advanced and decompensated congestive HF [22] or after 
cardiac surgery [27] show that the degree of mitochondrial 
dysfunction is associated with the disease severity and that 
this alteration gradually recovers after clinical stabilization. 
However, a fine characterization of mitochondrial changes 
linked to oxidative stress generation in circulating PBMCs 
isolated from chronic HF is still lacking. 
The purpose of this study was to characterize 
the involvement of mitochondrial dysfunction in the 
pathophysiology of HF by analyzing the mitochondrial 
structural and functional changes in relation to cell 
damage in circulating PBMCs isolated from chronic HF 
patients (HF_PBMCs). 
RESULTS
Characteristics of the study population
The main clinical and laboratory characteristics of 
the subjects included into the study are summarized in 
Table 1. In the HF group, all patients had chronic HF; 
14 of them presented with NYHA class I-II, 1 patient with 
stable NYHA class III. Among the HF patients, 14 had 
idiopathic dilated cardiomyopathy and one patient had 
history of myocarditis. Furthermore, five HF patients had 
associated renal failure. 
The PBMCs from HF patients are characterized 
by mitochondrial impairment and higher levels 
of oxidative stress
In order to analyze the mithocondrial function of 
HF_PBMCs with respect to PBMCs, we assessed levels 
of Δѱm and of cytoplasmic and mithocondrial ROS. 
The baseline level of cytoplasmic ROS did not show 
significant differences in the HF_PBMCs compared with 
the CTRL_PBMCs, though the proinflammatory stimulus 
with LPS induced a significant increase of cytoplasmic 
ROS in the HF_PBMCs (Figure 1A; p < 0.05). In contrast, 
the mitochondrial ROS levels detected with the MitoSOX 
Red were higher in the HF_PBMCs with respect to the 
CTRL_PBMCs, both at baseline condition and after 
LPS stimulation (Figure 1B; p < 0.05). As expected, the 
stimulation with H2O2 increased both cytoplasmic and 
mithocondrial oxidative stress particularly in HF_PBMCs 
(Figure 2A–2B; P < 0.05).
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The higher oxidative stress production in 
HF_PBMCs was also supported by the activation of 
counteracting pathways culminating with the upregulation 
of antioxidant genes. In fact, we found a significant 
difference of mRNA synthesis of Mn-superoxide 
dismutase (SOD-2) with respect to CTRL_PBMCs 
(Figure 1C; p < 0.05). In contrast, SOD activity was 
significantly decreased in the HF_PBMCs (Figure 1D; 
p < 0.05 and < 0.01). The GPx activity was also reduced 
in HF_PBMCs treated with the proinflammatory stimulus 
(Figure 1E; p < 0.05). This result would suggest either 
accelerated degradation or inactivation of the antioxidant 
mitochondrial enzymes during a stress condition [28]. 
The cytofluorimetric analysis of mitochondrial 
membrane potential by TMRM and JC-1 staining 
highlighted significant differences between the PBMCs 
groups, particularly following LPS stimulation, reflecting 
a significant mitochondrial depolarization in HF_PBMCs 
(Figure 1F–1H; p < 0.05).
Based on the above described functional data, we 
quantified the ultrastructural changes in mitochondria 
from HF and CTRL_PBMCs samples, stimulated or not as 
above, by two parameters of morphological damage: i) the 
percentage of mitochondrial area carrying intact cristae; 
and ii) the loss of IMM assessed as the IMM/OMM 
index. By applying the IMM/OMM index associated 
with convolution loss of inner mitochondrial membrane, 
we observed a significantly lower index values in the 
HF_PBMCs compared to CTRL_PBMCs at baseline with 
a further worsening after LPS-stimulation (Figure 2A–2B; 
p < 0.01). 
When using the grading scale of mitochondrial 
damage (Mt-G), HF_PBMCs showed a burden of overall 
damage, based on the distribution of Mt-G1 to Mt-G3 
levels, significantly higher with respect to CTRL_PBMCs 
both at baseline and after LPS stimulation (Figure 2C; 
p < 0.05). At the ultrastructural level the CTRL_PBMCs 
showed mitochondria with normal morphology or only 
with slight damage after stimulation (Figure 2D–2E). 
In contrast, the HF_PBMCs presented degeneration of 
convolutions related to lack of the IMM and also reduction 
of mitochondrial area with intact cristae (Figure 2F–2H). 
It is known that the preservation of mitochondrial 
integrity and function is critical for cell physiology. 
In response to various environmental stresses, cellular 
energy production can be disrupted and mitochondria 
become major producers of partially reduced species 
of molecular oxygen, which cause cellular damage also 
triggering the apoptotic pathway [7, 29–31]. To evaluate 
if the mitochondrial impairment in HF_PBMCs can also 
induce cytotoxic effects, cell damage was evaluated 
using annexin-V/PI staining. The flow cytometric 
analysis showed that the percentage of apoptotic cells 
in HF_PBMCs was significantly higher with respect to 
CTRL_PBMCs (Figure 3A–3C; p < 0.05). To confirm 
these data, an ultrastructural quantitative evaluation of cell 
damage was performed. Transmission electron microscopy 
revealed that the HF_PBMCs showed several features of 
cellular damage, such as apoptotic nuclei with areas of 
marginal, dense-stained chromatin and, less frequently, 
caryorrexis, caryolisis and fragmentation of cellular 
membranes (Figure 3D–3E; p < 0.05).
Altogether, our data indicate that the HF_PBMCs are 
characterized by mitochondrial dysfunction with increased 
generation of mitochondrial ROS and that, as expected, 
these conditions are associated with a strong alteration of 
Table 1: Clinical and laboratory characteristics of HF patients and control subjects
HF group
(Mean ± SD)
CTRL group
(Mean ± SD) Statistics
Age (years) 56.6 ± 10.8 49.3 ± 8 p = 0.10
Male sex (%) 80 80 p = 1
BMI (kg/m2) 28.1 ± 3.2 24.1 ± 2.4 p < 0.05
NYHA class I–II: 14 patients III: 1 patient 0 -
SBP/DBP (mmHg) 108 ± 2.5/65 ± 3 116 ± 2.5/70 ± 3 p = 0.26
LVEF (%) 28 ± 8 65 ± 2 p < 0.00001
LVEDD (mm) 67 ± 10 48 ± 3 p < 0.0001
LA size (mm) 48 ± 10 36 ± 2 p < 0.01
Creatinine (mg/dL) 1.19 ± 0.38 0.84 ± 0.2 p < 0.05
BUN (mg/dl) 27.8 ± 16.7 14.9 ± 1.9 p < 0.05
Hemoglobin (g/dl) 14.1 ± 1.7 14.8 ± 0.5 p = 0.2
BNP (pg/ml) 451 ± 672 NA -
Number of subjects 15 10 -
Abbreviations: LVEF: Left Ventricular Ejection Fraction, LVEDD: Left Ventricular End Diastolic Diameter, LA: Left 
Atrium, SBP/DBP: Systolic Blood Pressure/Diastolic Blood Pressure, NA: Not Assessed.
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Figure 1: Analysis of the mitochondrial function in PBMCs from HF and CTRL subjects. (A, B) Cytofluorimetric assay 
of cytoplasmic and mitochondrial ROS generation in unstimulated or stimulated PBMCs with LPS. The mitochondrial ROS levels were 
higher in PBMCs from HF respect to CTRL both at baseline and after LPS stimulation. As expected, the stimulation with H2O2 increased 
both cytoplasmic and mithocondrial oxidative stress particularly in HF_PBMCs. (C) A significant upregulation of the SOD-2 mRNA 
levels, as detected by RT-PCR, was found in HF_PBMCs with respect to CTRL_PBMCs, particularly after LPS stimulation (Mann–
Whitney test: *p < 0.05, **p < 0.01 and ^p = NS). (D, E) Assessment of antioxidant enzymes activity in supernatants of PBMCs cultures; 
the SOD and GPx activities were decreased in the HF_PBMCs compared to CTRL_PBMC (Student T test: *p < 0.05, **p < 0.01 and ^p = 
NS). (F–H) Cytofluorimetric assay for mitochondrial membrane potential (Δψm; TMRM staining) and mitochondrial depolarization index 
(JC-1 staining) in unstimulated or stimulated PBMCs with LPS. The data reflect a significant mitochondrial depolarization in HF_ with 
respect to CTRL_PBMCs. (Student T test: *p < 0.05, **p < 0.01 and ^p = NS). The panel G shows a JC-1 staining plot from representative 
PBMCs samples. 
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Figure 2: Quantitative analysis of ultrastructural damage in mitochondria from HF_ and CTRL_PBMCs. 
(A, B) Graphical representation of the IMM/OMM values. By applying the IMM/OMM index associated with convolution loss of inner 
mitochondrial membrane, we observed a significantly lower index values in the HF_ compared to CTRL_PBMCs at baseline condition 
with a further worsening after LPS-stimulation (Student T test: *p < 0.05 and **p < 0.01). Representative micrographs are displayed in 
B. (C) Graphical representation of the ultrastructural Mt-grading of damage. At baseline, the burden of overall damage was higher in 
HF_ with respect to CTRL_PBMCs; the standardized pro-inflammatory stimulus produced a strong increase of the mitochondrial overall 
damage both in the HF_ and CTRL_PBMCs (Student T test; *p < 0.05, **p < 0.01 and ^p = NS). (D–H) Representative micrographs of 
ultrastructural damage in mitochondria from human HF_ and CTRL_PBMCs. The burden of mitochondrial damage after LPS stimulation 
was higher particularly in HF_PBMCs (G–H); the mitochondria were characterized by degeneration of convolutions related to lack of 
the inner membrane and subsequently by reduction of mitochondrial area with intact cristae. The mitochondria of PBMCs obtained from 
healthy subjects showed mitochondria with normal morphology or only with slight damage after stimulation (D and E). The mitochondria 
of unstimulated HF_PBMCs displayed a pattern of intermediate damage (F). (TEM micrographs, uranyl acetate/lead citrate; Legend: NM, 
nuclear membrane, PM, plasma membrane; Nu, nucleus; ER, endoplasmic reticulum Gx: grade of mitochondrial damage).
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mitochondrial ultrastructure and with features of cellular 
damage. In addition, the standardized proinflammatory 
stimulation with LPS unmasked the mitochondrial failure 
that may not be overt at baseline condition.
The PBMCs from HF patients show an extensive 
activation of the mitophagic process similar to 
that of the PBMCs from healthy subjects upon 
inflammatory stress
As described above, in the presence of excessive 
ROS generation from aberrant mitochondria, the cells 
activate mitophagy. When mitophagy is triggered, a 
significant reduction of the mitochondrial pool is observed 
and the functionally compromised mitochondria appear 
smaller, rounded and with loss of internal cristae [32].
Indeed, the HF-PBMCs displayed organelles 
characterized by a significant reduction of the mitochondrial 
area and perimeter, with a total mitochondrial volume 
density smaller than in CTRL_PBMCs (Figure 4A–4C; 
p < 0.05). 
Then, to verify that oxidative stress and 
mitochondrial impairment also induce activation of 
selective autophagy of mitochondria in HF_PBMCs, 
Figure 3: Assessment of cell death in PBMCs obtained from HF and CTRL subjects. (A–C) The FACS analysis with 
Annexin V-FITC/PI staining showed that the percentage of apoptotic cells in HF_PBMCs was significantly higher with respect to CTRL_
PBMCs, particularly after LPS-stimulation (Student T test: *p < 0.05, **p < 0.01 and ^p = NS). The panel C shows a flow cytometric 
plot for Annexin/PI staining from representative PBMCs samples. (D and E) Ultrastructural quantitative evaluation of cell damage. 
The HF_PBMCs displayed a higher percentage of features of cell damage with respect to CTRL_PBMCs (Mann–Whitney test: *p < 
0.05). Representative micrographs of LPS-stimulated PBMCs (panel D) show the cytoplasmic vacuolization and apoptotic fragmentation 
characteristic of the necrotic or apoptotic cell death, respectively. (TEM micrographs, uranyl acetate/lead citrate.
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we analyzed the expression of genes involved in the 
mitophagic response, such as Beclin 1, Parkin and LC3 
[33]. The RT-PCR quantitation showed that the autophagic 
genes were upregulated in HF_PBMCs, as compared to 
CTRL_PBMCs, and that they were further upregulated 
in response to inflammatory stimulation (Figure 4D–4F; 
p < 0.05 to 0.01). In addition, in agreement with the gene 
expression data, the quantitative immunofluorescence 
analysis showed a significant increase of the LC3 signals 
in HF_PBMCs, that was even higher in the presence of the 
proinflammatory stimulus (p < 0.05 to 0.01; Figure 4G).
Next, to verify whether autophagy was specific 
for mitochondria, we examined mitochondrial mass in 
HF_ and CTRL_PBMCs. At baseline, the MitoTracker 
Green (MTG) assay showed levels of mitochondrial 
mass lower in HF_PBMCs compared to CTRL_PBMCs 
(Figure 4H; p < 0.05). After LPS-stimulation, CTRL_
PBMCs showed a net reduction of the mitochondrial mass 
whereas the HF_PBMCs maintained low levels of mass 
similar to that of unstimulated cells (Figure 4H: p = NS). 
Furthermore, the study of the mitophagic flux in 
the presence of lysosomal inhibitors revealed that the 
reduction of MTG staining in HF_PBMCs and in all 
stimulated PBMCs was blocked by the lysosomal inhibitor 
hydroxychloroquine (Figure 4H, p < 0.05). These data 
indicate that HF_PBMCs had higher levels of mitophagic 
flux at baseline, as compared to CTRL_PBMCs, and that 
the LPS-stimulation of the CTRL_PBMCs induced levels 
of mitophagic flux similar to that of the HF_PBMCs 
(Figure 4H, p = NS). 
To confirm the presence of mitochondrial 
degradation in HF_PBMCs, we performed an 
ultrastructural analysis that showed an extensive 
autophagy of mitochondria both in the absence of stimulus 
and after LPS stimulation (Figure 4I–4L).
Taken together, our results indicate that the 
mitochondrial dysfunction and the subsequent 
ultrastructural impairment of mitochondrial morphology 
in HF_PBMCs was associated with an extensive activation 
of the mitophagic process, similarly to that observed in the 
CTRL_PBMCs only under an inflammatory stress status.
DISCUSSION
The investigation of the pathogenetic mechanisms 
underlying the development and progression of HF 
is a fundamental step in order to improve diagnostic 
and therapeutic approaches. Our study focused on the 
characterization of one of the most complex mechanism 
involved in the pathogenesis of HF, the mitochondrial 
oxidative stress in tissue and blood [2, 34].
In this framework, ROS are derived from endogenous 
sources such as mitochondrial electron transport chain, 
nicotinamide adenine dinucleotide phosphate oxidase, nitric 
oxide synthase and xantine oxidase [35]. Their production, 
mostly due to circulating leukocytes involved in chronic 
inflammatory responses, is not adequately counteracted by 
the antioxidant scavenger systems [36]. 
In the present study, we focused our attention 
on a selected population of patients with chronic HF in 
the attempt to exclude any other conditions that could 
affect the production of oxidative stress. In PBMCs 
isolated from these highly selected patients with chronic 
HF, we evaluated ROS levels, mitochondrial function 
and morphology, the burden of cell damage and the 
mitophagic flux. The same evaluations were performed 
in a group of healthy subjects. Previous studies have 
shown that high levels of ROS and increased production 
of superoxide anion by neutrophils are present in the blood 
of HF patients [29, 37–39] and that white blood cells and 
platelets producing ROS can amplify oxidative stress and 
organ damage in HF [24]. Moreover, high concentrations 
of ROS in PBMCs of HF patients are able to determine the 
depolarization of mitochondrial structure and to trigger a 
programmed cell death [40]. 
As expected, our data show that HF patients have a 
PBMCs population producing an excess of ROS in relation 
with reduced mitochondrial functional performance and 
high scores of ultrastructural damage. The disruption of 
the inner mitochondrial membrane in these circulating 
cells, also documented by low IMM/OMM index values, 
is likely responsible of the electron transport chain 
impairment and of mitochondrial uncoupling ultimately 
leading to overproduction of superoxide anion and of other 
partially reduced species of molecular oxygen.
The activation of intracellular counteracting 
mechanisms, such as upregulation of antioxidant genes 
and enhancement of mitophagic flux, appear inadequate 
to maintain a proper mitochondrial dynamics in these 
conditions. Consequently, the cell microenvironment 
is more prone to oxidative stress and becomes trigger of 
inflammatory responses. Interestingly, the mitochondrial 
phenotype of the HF_PBMCs is similar to that of the 
CTRL_PBMCs undergoing experimental conditions that 
mimic inflammatory stress. As suggested by other studies, it 
is therefore likely that dysfunctional circulating leukocytes 
can act as an amplifier of oxidative stress and of cell 
damage at tissue level, therefore worsening the evolution 
of HF [22, 24].
A limitation of our study is represented by the 
limited number of HF patients enrolled for the analysis, 
as a consequence of the highly selected study criteria. On 
the other hand, the latter allowed us to avoid any other 
conditions producing oxidative stress.
In conclusion, our findings are consistent with 
the notion that HF is associated with an impairment of 
leukocyte function related to mitochondrial damage, 
increased oxidative stress and apoptosis [22]. The 
breakdown of the functional status of circulating leukocytes 
can contribute to the worsening of HF by promoting the 
impairment of the host defenses and by favouring the 
progression of the disease [26]. 
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Figure 4: Assessment of mitophagy activation in HF_ and CTRL_PBMCs. (A–C) Morphometric evaluation of mitochondrial 
structural parameters. At baseline, the HF-PBMCs displayed mitochondria characterized by a significant reduction of both area and 
perimeter and a total mitochondrial volume density smaller than in CTRL_PBMCs (Figure 4A–4C; *p < 0.05). (D–F) Analysis of mRNA 
expression of genes involved in the mitophagic response. The autophagic genes were more expressed in HF_PBMCs with respect to 
CTRL_PBMCs, and they were further upregulated in response to inflammatory stimulation (Mann–Whitney test: *p < 0.05; **p < 0.01). 
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Finally, we would like to stress the observation 
that the cytofluorimetric assessment of mitochondrial 
membrane potential and of mitochondrial ROS in HF_
PBMCs, as performed in our study, may represent useful 
tools for monitoring the oxidative stress at the cellular 
level, as they reflect the stress within the cardiovascular 
system [22]. This evidence may also open the way to new 
diagnostic and therapeutic approaches in HF management. 
In particular, targeting the mitochondrial dysfunction 
of circulating PBMCs may be a promising strategy to 
counteract HF development and progression. 
MATERIALS AND METHODS
Ethical standards
The study design was approved by the Institutional 
Review Board of the Sant’Andrea Hospital and Sapienza 
University of Rome (1916_15) The investigation conforms 
with the principles outlined in the Declaration of Helsinki. 
All patients gave their informed written consent to 
participate to the study.
Study subjects 
We examined 118 consecutive chronic HF patients, 
referring to the outpatient clinic of the Cardiology unit 
of Sant’Andrea Hospital in Rome from March 2015 
to August 2016. Out of them, we enrolled 15 patients 
matching the following inclusion criteria: age under 
70 years and ejection fraction of the left ventricle below 
40% (EF < 40%). The latter was measured with 2D echo 
Simpson’s biplane during mono-dimensional and bi-
dimensional echocardiography with a Siemens Acuson 
C200 apparatus. 
The patients with malignancy, inflammatory or 
infectious diseases, diabetes mellitus or ischemic heart 
disease, history of cigarette smoking and alcohol abuse 
were excluded. As a control group (CTRL) we enrolled 
ten healthy subjects referring to the transfusion center of 
the same hospital. 
PBMCs preparation and cultures
Venous blood specimens were obtained from both 
HF patients and CTRL group. Samples were drawn into 
collection tubes containing EDTA, delivered directly to the 
Ultrastructural Pathology Lab and immediately processed 
to isolate PBMCs using density gradient centrifugation 
over Ficoll-Paque™ PLUS (Amersham Biosciences/GE 
Healthcare). 
PBMCs were cultured in duplicate at the density of 
1 × 106 cells/ml on T25 flasks (Becton Dickinson, Oxnard, 
CA, USA) in RPMI-1640 supplemented with 10% fetal 
bovine serum and antibiotics. To unmask a possible 
status of mitochondrial dysfunction, they were treated 
or not with a standardized proinflammatory stimulus 
(1 µg/ml Lipopolysaccharide S (LPS; Sigma Chemicals 
Co.; St. Louis, MD, USA) at 37° C from 3 to 48 hrs) 
[41], or with a pro-oxidant stimulus (500 μmol Hydrogen 
Peroxide (H2O2) for 30 min). Cultured PBMCs were then 
divided into several aliquots and used for flow cytometry 
and for the ultrastructural evaluation. 
Assessment of cell damage 
Apoptosis was assessed by annexin V-FITC and PI 
(Annexin V-FITC kit, Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany). PBMCs were stained according 
to the manufacturer’s instructions and analyzed with 
MACSQuant Analyzer (Miltenyi Biotec GmbH). The 
excitation and emission wavelengths were 488/525 nm 
(B1 channel) for Annexin V-FITC and 488/655-730 nm 
(B3 channel) for PI detection. The flow cytometric data 
were supported by a transmission electron microscopy 
analysis with quantitative assessment of ultrastructural 
findings of cellular damage such as apoptotic nuclei, 
caryorrexis, caryolisis and fragmentation of cellular 
membranes. For this evaluation, at least 30 different 
microscopic fields were randomly acquired from ultrathin 
sections of each PBMCs sample and digitalized at 14,000× 
original magnification. 
Evaluation of oxidative stress
For intracellular ROS detection, the cells were 
incubated with 5 µM 2′,7′-dichlorofluorescein diacetate 
(DCFH-DA, Sigma-Aldrich, St. Louis, MO, USA) for 
10 min at 37° C for cytoplasmic oxidative stress 
assessment, or with 1µM MitoSOX™ Red mitochondrial 
superoxide indicator (Molecular Probes, Invitrogen, 
Eugene, OR, USA) for 15 min at 37° C for mitochondrial 
(G) Immunofluorescence assay of LC3 protein expression. bar = 20 μm The quantitative analysis showed a significant increase of the LC3 
fluorescence signals in HF_PBMCs, that was even higher in the presence of the proinflammatory stimulus (T Student test: *p < 0.05 and 
**p < 0.01). (H) Assessment of mitochondrial mass and mitophagic flux in HF and CTRL_PBMCs. At baseline, the MTG assay showed 
levels of mitochondrial mass lower in HF_PBMCs compared to CTRL_PBMCs. After LPS-stimulation, while CTRL_PBMCs showed a net 
reduction of the mitochondrial mass, the HF_PBMCs maintained low levels of mass similar to those of unstimulated cells. The reduction 
of MTG staining in HF-PBMCs and in the stimulated PBMCs was blocked by treatment with the lysosomal inhibitor HCQ. These data 
indicate that HF_PBMCs had higher levels of mitophagic flux at baseline, as compared to CTRL_PBMCs, and that the pro-inflammatory 
stimulus applied to CTRL_PBMCs induced levels of mitophagic flux similar to that of HF_PBMCs at baseline (Student T test: *p < 
0.05; p = NS). (I–L) Representative micrographs of mitochondria from HF_PBMCs. The ultrastructural analysis showed an extensive 
autophagy of mitochondria both in the absence of stimulus (I) and after LPS stimulation (J–L). (TEM micrographs, uranyl acetate/lead 
citrate; Abbreviations: NM, nuclear membrane, PM, plasma membrane, Nu, nucleus). 
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oxidative stress assessment, protected from light, 
extensively washed with PBS, re-suspended in pre-
warmed medium and collected with MACSQuantH 
Analyzer flow cytometer (Miltenyi Biotec GmbH). The 
excitation and emission wavelengths were 488/525 nm 
(B1 channel) for DCFH-DA and 488/585 nm (B2 channel) 
for MitoSOX™ Red detection. 
Assessment of antioxidant enzymes
For the superoxide dismutase (SOD) and glutathione 
peroxidase (GPx) levels, quantitative assays were 
performed on PBMCs culture supernatants following 
the manufacturer’s instructions by using commercial 
kits (RANSOD-superoxidodismutase and RANSEL-
glutathione peroxidase, Randox, Crumlin, UK).
Assessment of mitochondrial membrane 
potential
For mitochondrial membrane potential 
(Δψm) assessment, the cells were incubated with 
tetramethylrhodamine methyl ester (TMRM, Molecular 
Probes, Invitrogen) 500 nM for 30 min at 37° C and with 5, 
5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazolylcarb
ocyanine iodide 1.5 μM (JC-1, Molecular Probes) for 30 min 
at 37° C. The samples were protected from light, washed 
with warmed PBS, resuspended in pre-warmed medium 
and collected with MACSQuantH Analyzer flow cytometer. 
The excitation and emission wavelengths were 488/585 nm 
(B2 channel) for TMRM analysis and 488/525 to 585 nm 
(B1 + B2 channels) for JC-1 polychromatic fluorescence 
emission evaluation. 
Evaluation of mitochondrial mass
Mitochondrial mass was measured by a 
cytofluorimetric assay upon staining with MitoTracker 
Green FM (MTG-FM; Molecular Probes, Invitrogen) 
50 nM for 30 minutes at 37° C. Excitation wavelength 
was 488 nm and fluorescence emission was measured at 
585 nm (B1 channel). 
Analysis of cytofluorimetric signals
All fluorescence signals obtained from the flow 
cytometer were analysed by MACSQuantify software 
(Miltenyi Biotec GmbH) and visualized on a three-decade 
log scale. The mean fluorescence intensity (MFI ± SE) of 
TMRM, DCFH-DA and Mito-SOX was calculated from 
three independent experiments with evaluation of at least 
20,000 events for assay.
Transmission electron microscopy and 
mitochondrial morphometry assessment
PBMCs treated as above were washed three-
times in PBS and fixed with 2% glutaraldehyde in PBS 
for 2 hours at 4° C. Samples were post-fixed with 1% 
osmium tetroxide in veronal acetate buffer pH 7.4 for 
1 hour at 25° C, stained with uranyl acetate (5 mg/ml) 
for 1 hour at 25° C, dehydrated in acetone and embedded 
in Epon 812 (EMbed 812, Electron Microscopy Science, 
Hatfield, PA, USA). Ultrathin sections obtained with an 
Ultracut EMFCS ultramicrotome (Leica Microsystems, 
Wetzlar, Germany) were unstained or poststained with 
uranyl acetate and lead hydroxide, and examined under 
a Morgagni 268D Transmission Electron Microscope 
(TEM) (FEI, Hillsboro, OR, USA) equipped with a Mega 
View II charge-coupled device camera (SIS, Soft Imaging 
System GmbH, Munster, Germany).
For the two-dimensional morphometric analysis 
of mitochondria, at least 20 cell sections in ten different 
microscopic fields were randomly captured from ultrathin 
sections of each PBMCs sample and digitalized at 28,000 
× original magnification. Area (A) and Perimeter (P) of all 
mitochondria were measured with the AnalySIS software 
(Soft Imaging System). The three-dimensional measures 
of Sphericity and Volume were subsequently derived 
according to the methods proposed by Noto et al. [42].
The sphericity of each structure was expressed by 
calculating the Shape Factor: 
φ =
pi
pi
4A
P
.
The Volume (μm3) was corrected for Shape Factor 
and calculated by applying the following formula: 
V p= 




φ
4
3 2
3pi
pi .
The derived mitochondrial volumetric fraction 
(mitochondrial volume density) was calculated by 
applying the formula: MVF
tmV
cV
=  (tmV: total mitochondrial 
Volume; cV: cellular Volume).
Ultrastructural quantitation of mitochondrial 
damage
At least 30 cell sections, randomly taken in ten 
different microscopic fields, obtained from ultrathin 
sections of each PBMCs sample were acquired at 
28,000× original magnification and digitalized with 
a Mega View II charge-coupled device camera (Soft 
Imaging System). 
The micrographs were analyzed with the AnalySIS 
software (Soft Imaging System) for the percentage of 
damaged mitochondria classified using a grading scale 
based on the mitochondrial area with intact cristae, 
as previously described [41]. Thus, injury grading 
was categorized into three levels of morphological 
mitochondria damage: Mt-G3, severe; Mt-G2, moderate 
and Mt-G1, slight, corresponding to 0%, 1–50% and 
51–75% of the area occupied by intact cristae. An 
additional parameter of the mitochondrial injury was 
the convolution degeneration related to the inner 
Oncotarget35038www.oncotarget.com
mitochondrial membrane (IMM) length [13, 14, 43]. All 
mitochondria observed in 20 ultrathin sections, randomly 
taken at 56,000 X for all PBMCs samples, were measured 
for both lengths of IMM and OMM; hence, the IMM/
OMM index was calculated for each mitochondrion. 
Mitochondrial damage was correlated to a low mean value 
of IMM/OMM index, corresponding to partial or total loss 
of IMM cristae. 
Immunofluorescence
For the immunofluorescence analysis, PBMCs 
were fixed with 4% paraformaldehyde followed by 
treatment with 0.1 M glycine for 20 min at 25° C and with 
0.1% Triton X-100 for additional 5 min at 25° C for cell 
membrane permeabilization. Cells were then incubated 
with mouse monoclonal anti-LC3 (1:100 in PBS; 5F10 
312 Nanotools, Teningen, Germany) for 1 hour at 25° C. 
The primary antibody was visualized, after appropriate 
washing with PBS, by using goat anti-mouse IgG–FITC 
(1:50 in PBS; Cappel Research Products, Santa Ana, 
CA, USA) for 30 min at 25° C. Nuclei were stained with 
4,6-diamidino-2-phenylindole dihydrochloride (DAPI, 
1 : 10,000; Sigma Chemicals, St. Louis, MO, USA). 
Quantitative analysis of the LC3 fluorescence intensity for 
cytoplasmic area was performed by the analysis of at least 
100 cells for each sample in five different fields randomly 
taken from three independent experiments and performed 
by the Axiovision software (Zeiss).
 Assessment of mitophagic flux
For the inhibition of the autophagic flux, PBMCs 
were treated with 30 μM hydroxychloroquine (HCQ, 
Sigma) for 3 hrs to block lysosomal degradation. 
Subsequently, they were stimulated or not with LPS 
1 µg/ml for 3 hrs. After treatment, PBMCs were divided 
into several aliquots and they were used for flow 
cytometry and PCR assays, as described above, and for 
the mitochondrial morphometry assessment by TEM. 
The mitophagy flux compares the mitochondrial mass 
with and without lysosomal inhibitors (PBMCs_HCQ+/
PBMCs_HCQ- fluorescence levels) normalized to the 
corresponding value in control cells. The mitochondrial 
mass was evaluated by a cytofluorimetric assay (MTG-FM 
levels) [44, 45] and with a novel morphometric approach 
(MVF values). 
RNA extraction and cDNA synthesis 
RNA was extracted by using the Quick-RNA™ 
MiniPrep (Zymo Research, Irvine, CA, USA) according to 
the manufacturer’s instructions. Each sample was treated, 
quantified and 1 μg was used to reverse transcription 
by using the iScript cDNA synthesis kit (Bio-Rad) with 
thermal cycling programme as follows: 25° C for 5 min, 
followed by 46° C for 20 min and 95° C for 1 min.
Primers 
The amplification of the cDNA fragments of 
target genes expression and of the ribosomal 18S RNA 
(housekeeping gene) was obtained by using specific 
oligonucleotides chosen through the online tool Primer-
BLAST42 and purchased from Invitrogen (Invitrogen, 
Carlsbad, CA, USA). Primers list and characteristics are 
reported in Table 2. For each primer pair, we performed 
a no-template control which produced negligible signals.
RT-PCR quantitation
RT-PCR was carried out in 96-well plates by using 
the iQ SYBR Green Supermix (Bio-Rad) and the iCycler 
Real-Time Detection System (iQ5; Bio-Rad). The thermal 
cycling programme was performed as follows: an initial 
denaturation step at 95° C for 3 min, followed by 40 cycles 
at 95° C for 10 s and 60° C for 30 s. Melting curves were 
performed for each primer pair. The relative quantification 
of gene expression was assessed by comparative threshold 
cycle method (2−ΔΔCT), including normalization of the 
gene expression to ribosomal 18 S RNA, showing a stable 
expression in all experimental conditions. All experiments 
Table 2: Primers used for target and housekeeping genes
Gene Primer sequence 
18s 5′-AACCAACCCGGTCAGCCCCT- 3′ (sense), 
5′-TTCGAATGGGTCGTCGCCGC- 3′ (antisense)
SOD-2 5′-GGTGGAGAACCCAAAGGGGAGTTG- 3′ (sense)
5′-TTATTGAAACCAAGCCAACCCCAACCT- 3′ (antisense)
Beclin-1 5′-GGATGGTGTCTCTCGCAGAT- 3′ (sense)
5′-TTTCTTGCCCTTCCTTTCTG- 3′ (antisense)
Parkin 5′-GGCTGTGGGTTTGCCTTCT-3′ (sense)
5′-TGCTTCCCAACGAGCCTG-3′ (antisense)
LC3 5′-CGCACCTTCGAACAAAGAG- 3′ (sense)
5′-TTGGCACTTTCTGTGGACAT- 3′ (antisense)
Oncotarget35039www.oncotarget.com
were performed in triplicate and values are reported as 
mean ± SD.
Statistical methods
Student’s T test was used to evaluate statistical 
significance among variables with a normal distribution. 
The values are expressed as mean ± SE. Mann–Whitney 
non-parametric tests was used to compare variables 
without a normal distribution. The values are expressed as 
median ± Interquartile Ranges (IR) from three independent 
experiments. P values < 0.05 were assumed as statistically 
significant.
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